Escherichia coli-derived virus-like particles in vaccine development
Abstract Recombinant virus-like particle-based vaccines are composed of viral structural proteins and mimic authentic native viruses but are devoid of viral genetic materials. They are the active components in highly safe and effective vaccines for the prevention of infectious diseases. Several expr...
Guardado en:
Autores principales: | Xiaofen Huang, Xin Wang, Jun Zhang, Ningshao Xia, Qinjian Zhao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2f5ce63bc4174acb969cb8228053d3b9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines
por: Mohammad W. Bahar, et al.
Publicado: (2021) -
Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes
por: Raffaello Verardi, et al.
Publicado: (2020) -
A single-dose live attenuated chimeric vaccine candidate against Zika virus
por: Wei-Xin Chin, et al.
Publicado: (2021) -
A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
por: Thomas W. Geisbert, et al.
Publicado: (2021) -
Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses
por: Christopher L. D. McMillan, et al.
Publicado: (2021)